NLM logo
Search help
55 results
  1. UMLS Metathesaurus - NCI (NCI Thesaurus) - Source Representation 
    https://www.nlm.nih.gov/.../current/NCI/sourcerepresentation.html
    ... for Adverse Events 3.0 CTCAE_5 Common Terminology Criteria for Adverse Events 5.0 CTEP-SDC Cancer Therapy Evaluation Program - Simple Disease Classification CTRP Clinical Trials Reporting Program DCP NCI Division of Cancer Prevention Program ...
  2. UMLS Metathesaurus - NCI (NCI Thesaurus) - Metathesaurus Representation 
    https://www.nlm.nih.gov/.../current/NCI/metarepresentation.html
    ... for Adverse Events 3.0 CTCAE_5 Common Terminology Criteria for Adverse Events 5.0 CTEP-SDC Cancer Therapy Evaluation Program - Simple Disease Classification CTRP Clinical Trials Reporting Program DCP NCI Division of Cancer Prevention Program ...
  3. pdf2017MeshTreesWithChangesShown.pdf 
    https://www.nlm.nih.gov/.../2017MeshTreesWithChangesShown.pdf
    ... Pilot Projects Product Surveillance, Postmarketing Adverse Drug Reaction Reporting Systems Clinical Trials, Phase IV as Topic Pharmacovigilance Program Evaluation Reproducibility of Results Dimensional Measurement Accuracy Validation ...
  4. pdfNational Library of Medicine Programs and Services FY2013 
    https://www.nlm.nih.gov/ocpl/anreports/fy2013.pdf
    ... the ClinicalTrials.gov program and praised it. The program continued to provide ... and for reporting to results databases. For example, a key activity ...
  5. pdfHTA 101 - INTRODUCTION TO HEALTH TECHNOLOGY ASSESSMENT 
    https://www.nlm.nih.gov/nichsr/hta101/HTA_101_FINAL_02-02-15.pdf
    ... above, there are other instruments for assessing the reporting of clinical trials, systematic reviews, meta-analyses of trials, meta-analyses of observational studies, and economic analyses. Some of these are listed in Box IV-3 . HTA programs that use the inclusion/exclusion rules and other ...
  6. pdf2016MeshTree.pdf 
    https://www.nlm.nih.gov/mesh/2016/download/2016MeshTree.pdf
    ... Postmarketing E05.337.800.120...........................................Adverse Drug Reaction Reporting ... of Results E05. ...
  7. Prioritization and Selection of Harms for Inclusion in Systematic Reviews - Methods Guide for Effectiveness and ... 
    https://www.ncbi.nlm.nih.gov/books/NBK519367
    ... to identify important harms. Use consistent and precise terminology ... when clinical trials are lacking; when generalizability is uncertain; or when ...
  8. Congressional Justification FY 2021 
    https://www.nlm.nih.gov/about/2021CJ.html
    ... Department of Agriculture (USDA); enhancing registration and results ... extramural programs. NLM will continue to leverage the National Network ...
  9. pdfCongressional Justification NLM 2021 
    https://www.nlm.nih.gov/about/2021CJ_NLM.pdf
    ... Department of Agriculture (USDA); enhancing registration and results ... extramural programs. NLM will continue to leverage the National Network ...
  10. 2019New_Mesh_Tree_Hierarchy.txt 
    https://www.nlm.nih.gov/.../download/2019New_Mesh_Tree_Hierarchy.txt
    ... Postmarketing E05.337.800.120 Adverse Drug Reaction Reporting Systems E05.337.800.200 Clinical Trials, Phase IV as Topic E05.337.800.600 Pharmacovigilance E05.337.800.800 Prescription Drug Monitoring Programs E05.337.820 Program Evaluation E05.337.851 ...
first · previous · 1 · 2 · 3 · 4 · 5 · 6 · next · last